4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-034060
Chief Legal Officer gave up 9,534 shares (to pay taxes)
- Chief Legal Officer acquired 33,188 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…